Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 4

3(42.9%)

Phase 2

1(14.3%)

Phase 3

1(14.3%)

N/A

1(14.3%)

Phase 1

1(14.3%)

7Total

Phase 4(3)

Phase 2(1)

Phase 3(1)

N/A(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04152551Phase 4Recruiting

Effects of Bisphosphonates on OI-Related Hearing Loss

Role: collaborator

NCT07325435Phase 4Active Not Recruiting

Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

Role: collaborator

NCT05643196Phase 2Completed

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

Role: collaborator

NCT04767061Phase 4Completed

Impact of Beta-blockers on Physical Function in HFpEF

Role: collaborator

NCT01784523Phase 3Terminated

Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients

Role: collaborator

NCT01292096Phase 1Completed

Intervening With and Improving Care for Patients at Risk for Frequent Hospital Admissions

Role: collaborator

NCT00248924Completed

Outcomes Of Social Service Programs For Homebound Older Adults

Role: collaborator

NCT00249327Not ApplicableCompleted

Online HIV Prevention Vignette Evaluation

Role: collaborator

All 8 trials loaded